Your browser doesn't support javascript.
loading
A prognostic survival nomogram for persons with extra-nodal natural killer-/T-cell lymphoma.
Wang, Hua; Fu, Bi-Bo; Wuxiao, Zhi-Jun; Li, Ya-Jun; Huang, Li; Ma, Jie; Zhai, Zhi-Min; Guo, Jing; Wu, Yuan-Bin; Xu, Zhen-Shu; Feng, Jia; Zhou, Sheng-Sheng; Chen, Ting-Ting; Chen, Xing-Gui; Li, Guo-Wei; Liu, Ting-Zhi; Huang, Hai-Bin; Zheng, Run-Hui; Li, Yong-Hua; Tao, Hong-Fang; Zi, Fu-Ming; Wu, Fan; Wang, Juan; Zeng, Hui; Fu, Cai-Bo; Gale, Robert Peter; Xia, Zhong-Jun; Liang, Yang.
Afiliación
  • Wang H; Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China.
  • Fu BB; Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China.
  • Wuxiao ZJ; Department of Hematology, Lymphoma and Myeloma Center, HMC Cancer Institute, The First Affiliated Hospital of Hainan Medical University, Haikou City, Hainan, PR China.
  • Li YJ; Department of Lymphoma and Hematology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, PR China.
  • Huang L; Department of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, PR China.
  • Ma J; Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, PR China.
  • Zhai ZM; Department of Hematology, The Second Hospital of Anhui Medical University, Hefei, Anhui, PR China.
  • Guo J; Department of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, PR China.
  • Wu YB; Department of Hematology, Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong, PR China.
  • Xu ZS; Department of Hematology, Fujian Medical University Union Hospital, Fuzhou, Fujian, PR China.
  • Feng J; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, PR China.
  • Zhou SS; Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, PR China.
  • Chen TT; Department of Hematology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University), Shenzhen, PR China.
  • Chen XG; Cancer Center, Affiliated Hospital, Guangdong Medical University, Zhanjiang, Guangdong, PR China.
  • Li GW; Department of Hematology, Huizhou Municipal Central Hospital, Huizhou, Guangdong, PR China.
  • Liu TZ; Department of Medical Hematology, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangdong gastrointestinal hospital, Guangzhou, Guangdong, PR China.
  • Huang HB; Department of Hematology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, PR China.
  • Zheng RH; Department of Hematology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China.
  • Li YH; Department of Hematology, General Hospital of Southern Theater Command, PLA, Guangzhou, Guangdong, PR China.
  • Tao HF; The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, PR China.
  • Zi FM; Department of Hematology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China.
  • Wu F; Department of Hematology, The Second Hospital of Anhui Medical University, Hefei, Anhui, PR China.
  • Wang J; Department of Hematology, The Second Hospital of Anhui Medical University, Hefei, Anhui, PR China.
  • Zeng H; Department of Hematology, The First Affiliated Hospital of Jinan university, Guangzhou, Guangdong, PR China.
  • Fu CB; Department of Hematology, Lymphoma and Myeloma Center, HMC Cancer Institute, The First Affiliated Hospital of Hainan Medical University, Haikou City, Hainan, PR China.
  • Gale RP; Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China.
  • Xia ZJ; Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, UK.
  • Liang Y; Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China. xiazhj@sysucc.org.cn.
Leukemia ; 36(11): 2724-2728, 2022 11.
Article en En | MEDLINE | ID: mdl-35970944
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Linfoma Extranodal de Células NK-T / Células T Asesinas Naturales Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Linfoma Extranodal de Células NK-T / Células T Asesinas Naturales Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article